ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP20-26 Commercial and MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective May 1, 2026
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါမာ်ရှး 11, 2026
တၢ်ဃုသ့ၣ်ညါတၢ်အစၢ
တၢ်ပာ်ဖျါ 4081 - 4090 လၢ 4226 အစၢတဖၣ်အကျါ
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP19-26 Commercial Pharmacy Benefit Exclusion for Select Medications
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါမာ်ရှး 11, 2026
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP18-26 MHCP Pharmacy Benefit Exclusion for Lunsumio Velo™ and Yartemlea™
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါမာ်ရှး 11, 2026
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP17-26 Commercial Pharmacy Benefit Exclusion for Yartemlea™
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါမာ်ရှး 11, 2026
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP16-26 Diabetic Supplies for Medicare Subscribers
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါမာ်ရှး 11, 2026
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP15-26 Provider Press: Q1 2026
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါမာ်ရှး 11, 2026
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP14-26 Early Intensive Developmental and Behavioral Intervention (EIDBI) Qualified Supervising Professional (QSP) Requirements
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါမာ်ရှး 11, 2026
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP13-26 Early Intensive Developmental and Behavioral Intervention (EIDBI) Provisional License
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါမာ်ရှး 11, 2026